Pirbuterol

In the US, Pirbuterol (pirbuterol systemic) is a member of the drug class adrenergic bronchodilators and is used to treat Asthma - acute, Asthma - Maintenance, COPD - Acute and COPD - Maintenance.

US matches:

• Pirbuterol


• Pirbuterol inhalation


• Pirbuterol inhaler


• Pirbuterol Acetate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R03AC08,R03CC07

CAS registry number (Chemical Abstracts Service)

0038677-81-5

Chemical Formula

C12-H20-N2-O3

Molecular Weight

240

Therapeutic Category

Bronchodilator

Chemical Name

2,6-Pyridinedimethanol, α6-[[(1,1-dimethylethyl)amino]methyl]-3-hydroxy-

Foreign Names

• Pirbuterolum (Latin)
• Pirbuterol (German)
• Pirbutérol (French)
• Pirbuterol (Spanish)

Generic Names

• Pirbuterol (OS: BAN)
• Pirbutérol (OS: DCF)
• CP 24315-1 (IS)
• Pyrbuterol (IS)
• Pirbuterol Acetate (OS: USAN, BANM)
• CO 24314-14 (IS: Pfizer)

Brand Names

• Maxair
  Graceway, United States



• Spirolair
  3M, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.